Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its artificial pancreas system for people with Type 1 diabetes. The California ...

Patients were classified as follows: NF-PNETs (28.3%), insulinomas (54.0%), and other functioning PNETS (OF-PNETs) (9.7%), including 4 glucagonomas, 2 gastrinomas, 1 gastrinoma-glucagonoma, 2 ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%. In pancreatic cancer, symptoms ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

Pancreatic cancer, one of the most formidable, could soon see its treatment transformed. Researchers have identified an enzyme, Mical2, which plays a central role in the progression of this disease.

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...